Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 May;83(5):1778–1781. doi: 10.1172/JCI114082

The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.

P J Newman 1, R S Derbes 1, R H Aster 1
PMCID: PMC303891  PMID: 2565345

Abstract

The human platelet alloantigens, PlA1 and PlA2, comprise a diallelic antigen system located on a component of the platelet fibrinogen receptor, membrane glycoprotein (GP) IIIa. Of the known platelet alloantigens, PlA1, which is carried by 98% of the caucasian population, appears to be the alloantigen that most often provokes neonatal alloimmune thrombocytopenic purpura and posttransfusion purpura. The structural features of the GPIIIa molecule responsible for its antigenicity are as yet unknown. Using the polymerase chain reaction (PcR), we amplified the NH2-terminal region of platelet GPIIIa mRNA derived from PlA1 and PlA2 homozygous individuals. Nucleotide sequence analysis of selected amplified cDNA products revealed a C in equilibrium T polymorphism at base 196 that created a unique Nci I restriction enzyme cleavage site in the PlA2, but not the PlA1 form of GPIIIa cDNA. Subsequent restriction enzyme analysis of cDNAs generated by PcR from 10 PlA1/A1, 5 PlA2/A2, and 3 PlA1/A2 individuals showed that Nci I digestion permitted clear discrimination between the PlA1 and PlA2 alleles of GPIIIa. All PlA2/A2 individuals studied contain a C at base 196, whereas PlA1 homozygotes have a T at this position. This single base change results in a leucine/proline polymorphism at amino acid 33 from the NH2-terminus, and is likely to impart significant differences in the secondary structures of these two allelic forms of the GPIIIa molecule. The ability to perform DNA-typing analysis for PlA phenotype may have a number of useful clinical applications, including fetal testing and determination of the phenotype of severely thrombocytopenic individuals.

Full text

PDF
1778

Images in this article

1780Image
on p.1780
1780Image
on p.1780

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aster R. H. Clinical significance of platelet-specific antigens and antibodies. Prog Clin Biol Res. 1984;149:103–118. [PubMed] [Google Scholar]
  2. Burk C., Ingram C., Weiner M., Rappaport E. F., Schwartz E., Poncz M. A Taq 1 polymorphism for the human platelet glycoprotein IIIa gene (GP3A). Nucleic Acids Res. 1988 Jul 25;16(14B):7216–7216. doi: 10.1093/nar/16.14.7216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fitzgerald L. A., Steiner B., Rall S. C., Jr, Lo S. S., Phillips D. R. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin". J Biol Chem. 1987 Mar 25;262(9):3936–3939. [PubMed] [Google Scholar]
  4. Furihata K., Nugent D. J., Bissonette A., Aster R. H., Kunicki T. J. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest. 1987 Dec;80(6):1624–1630. doi: 10.1172/JCI113250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kunicki T. J., Newman P. J. The biochemistry of platelet-specific alloantigens. Curr Stud Hematol Blood Transfus. 1986;(52):18–32. doi: 10.1159/000412261. [DOI] [PubMed] [Google Scholar]
  6. Lench N., Stanier P., Williamson R. Simple non-invasive method to obtain DNA for gene analysis. Lancet. 1988 Jun 18;1(8599):1356–1358. doi: 10.1016/s0140-6736(88)92178-2. [DOI] [PubMed] [Google Scholar]
  7. Newman P. J., Gorski J., White G. C., 2nd, Gidwitz S., Cretney C. J., Aster R. H. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest. 1988 Aug;82(2):739–743. doi: 10.1172/JCI113656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Newman P. J., Martin L. S., Knipp M. A., Kahn R. A. Studies on the nature of the human platelet alloantigen, PlA1: localization to a 17,000-dalton polypeptide. Mol Immunol. 1985 Jun;22(6):719–729. doi: 10.1016/0161-5890(85)90103-8. [DOI] [PubMed] [Google Scholar]
  9. Phillips D. R., Charo I. F., Parise L. V., Fitzgerald L. A. The platelet membrane glycoprotein IIb-IIIa complex. Blood. 1988 Apr;71(4):831–843. [PubMed] [Google Scholar]
  10. Rosa J. P., Bray P. F., Gayet O., Johnston G. I., Cook R. G., Jackson K. W., Shuman M. A., McEver R. P. Cloning of glycoprotein IIIa cDNA from human erythroleukemia cells and localization of the gene to chromosome 17. Blood. 1988 Aug;72(2):593–600. [PubMed] [Google Scholar]
  11. Shulman N. R., Aster R. H., Leitner A., Hiller M. C. IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY". J Clin Invest. 1961 Sep;40(9):1597–1620. doi: 10.1172/JCI104383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Woods V. L., Jr, Oh E. H., Mason D., McMillan R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood. 1984 Feb;63(2):368–375. [PubMed] [Google Scholar]
  13. Zimrin A. B., Eisman R., Vilaire G., Schwartz E., Bennett J. S., Poncz M. Structure of platelet glycoprotein IIIa. A common subunit for two different membrane receptors. J Clin Invest. 1988 May;81(5):1470–1475. doi: 10.1172/JCI113478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. van der Schoot C. E., Wester M., Von Dem Borne A. E., Huisman H. G. Characterization of platelet-specific alloantigens by immunoblotting: localization of Zw and Bak antigens. Br J Haematol. 1986 Dec;64(4):715–723. doi: 10.1111/j.1365-2141.1986.tb02233.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES